V Square Quantitative Management LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

V Square Quantitative Management LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 7.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 5,762 shares of the healthcare conglomerate’s stock after acquiring an additional 416 shares during the period. V Square Quantitative Management LLC’s holdings in UnitedHealth Group were worth $2,915,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in UNH. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the third quarter valued at about $37,000. Friedenthal Financial purchased a new position in shares of UnitedHealth Group in the third quarter valued at about $51,000. DecisionPoint Financial LLC lifted its position in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares in the last quarter. Finally, Highline Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group in the third quarter worth about $55,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.7 %

Shares of NYSE:UNH opened at $531.31 on Friday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market cap of $488.96 billion, a P/E ratio of 34.28, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The business’s 50 day moving average is $524.58 and its 200 day moving average is $563.71. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. TD Cowen boosted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Truist Financial reduced their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Finally, Oppenheimer boosted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.